Pancreatic cancer trials in China

In China 326 Also abroad 1094

326 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 2Not yet taking people in China
Intestinal Low-Dose Radiotherapy Combined With Immune Checkpoint Inhibitors in Solid Tumors With Liver Metastases
Where
Hangzhou
Age
18 years and over
People
120
Run by
Bing Xia
See details and how to joinNCT07875465
Phase 1Not yet taking people in China
Phase 1 Study of NW-301V TCR-T Cells in Advanced Solid Tumors With KRAS G12V Mutation
Where
Beijing, Hangzhou
Age
18 years to 75 years
People
66
Run by
Neowise Biotechnology
See details and how to joinNCT07875920
Phase 2/3Taking people
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Where
Baoding, Beijing, Dalian, Fuzhou, Guangzhou, Hangzhou, Hefei, Huzhou, Jinan, Langfang, Lanzhou, Shanghai, Shenzhen, Taiyuan, Wenzhou, Xi’an, Zhengzhou
Age
18 years and over
People
982 worldwide
Run by
Pfizer
See details and how to joinNCT06989437 · EU 2025-522093-36-00
Phase 1Taking people
Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors
Where
Beijing
Age
18 years and over
People
167
Run by
Shandong Boan Biotechnology Co., Ltd
See details and how to joinNCT06596915
Phase 2Taking people
Stereotactic Body Radiotherapy and NALIRIFOX for Locally Advanced Pancreatic Cancer
Where
Jinan
Age
18 years to 75 years
People
42
Run by
Shandong Cancer Hospital and Institute
See details and how to joinNCT07173387
No phaseTaking people
Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer
Where
Jinan
Age
18 years to 75 years
People
56
Run by
Shandong Cancer Hospital and Institute
See details and how to joinNCT07408505
Phase 2Taking people
SBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic Cancer
Where
Jinan
Age
18 years to 75 years
People
47
Run by
Shandong Cancer Hospital and Institute
See details and how to joinNCT07683221
Phase 3Taking people
A Multicenter Study of IBI343 Monotherapy Versus Placebo in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, Pancreatic Cancer(G-HOPE-002)
Where
Shanghai
Age
18 years and over
People
201
Run by
Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT07066098
Phase 1/2Taking people
A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation
Where
Beijing, Chengdu, Guangzhou, Hangzhou, Harbin, Jinan, Shanghai, Shenyang, Wuhan, Xi’an, Zhengzhou
Age
18 years and over
People
222 worldwide
Run by
Genfleet Therapeutics (Shanghai) Inc.
See details and how to joinNCT07678593
Phase 2Taking people
A Phase II Study of GFH375 Combined With GFS202A or GFH276 Versus GFH375 in Patients With Previously Treated Locally Advanced Unresectable or Metastatic Pancreatic Cancer Harboring KRAS G12D Mutation
Where
Shanghai
Age
18 years to 80 years
People
120
Run by
Genfleet Therapeutics (Shanghai) Inc.
See details and how to joinNCT07784374
Phase 2Not yet taking people in China
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Where
Changsha, Chengdu
Age
18 years and over
People
226 worldwide
Run by
AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00
Phase 1/2Taking people
Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
Where
Beijing, Shandong
Age
18 years and over
People
392 worldwide
Run by
AstraZeneca
See details and how to joinNCT06005493 · EU 2023-504139-42-00
Phase 2Taking people
Lenvatinib Plus Chemotherapy for pNET Liver Metastases
Where
Beijing
Age
18 years to 75 years
People
80
Run by
Peking Union Medical College Hospital
See details and how to joinNCT07835893
Phase 2Not yet taking people in China
Surufatinib in Combination With Iparomlimab and Tuvonralimab Injection and AG Chemotherapy for Neoadjuvant Therapy of HRPC or BRPC
Where
Shanghai
Age
18 years to 75 years
People
56
Run by
Shanghai Zhongshan Hospital
See details and how to joinNCT07833241
Phase 1/2Taking people
Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Where
Hangzhou
Age
18 years and over
People
120 worldwide
Run by
Betta Pharmaceuticals Co., Ltd.
See details and how to joinNCT07435038
Phase 2Not yet taking people in China
Albumin-bound Paclitaxel (Ⅱ)-Combined Regimens for Pancreatic Cancer
Where
Tianjin
Age
18 years to 75 years
People
147
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07828756
Phase 2/3Taking people
A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer
Where
Anyang, Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guandong, Haikou, Hangzhou, Harbin, Hefei, Jinan, Jining, Kunming, Linyi, Nanchang, Nanjing, Nanning, Nantong, Qinhuangdao, Shanghai, Shenyang, Shenzhen, Suzhou, Taiyuan, Tianjin, Wenzhou, Wuhan, Wuxi, Xiamen, Xi’an, Xinxiang, Zhengzhou
Age
18 years to 75 years
People
502
Run by
Hutchmed
See details and how to joinNCT06361888
Phase 2Not yet taking people in China
Protein-Matched ADC or PDC Umbrella Trial in Advanced Pancreatic and Breast Cancer
Where
Shanghai
Age
18 years to 75 years
People
225
Run by
Fudan University
See details and how to joinNCT07825753
No phaseNot yet taking people in China
Five-Element Music Therapy for Psychological Distress in Pancreatic Cancer Chemotherapy
Where
Tianjin
Age
18 years and over
People
320
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07796906
Phase 3Taking people
Study of XNW28012 in Subjects With Metastatic Pancreatic Cancer Who Received Prior Systemic Therapy
Where
Beijing, Binzhou, Changsha, Changzhou, Chengdu, Chongqing, Fuyang, Fuzhou, Guangzhou, Ha’erbin, Hangzhou, Hefei, Jilin City, Jinan, Lanzhou, Meizhou, Nanchang, Nanjing, Nanning, Neimeng, Ningbo, Shanghai, Shenyang, Taiyuan, Tianjin, Wuhan, Xiamen, Xi'an, Xiangyang, Yangzhou, Yinchuan, Zhengzhou
People
226
Run by
Evopoint Biosciences Inc.
See details and how to joinNCT07823049
Phase 1Taking people
NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor
Where
Beijing
Age
18 years to 75 years
People
12
Run by
Peking University
See details and how to joinNCT06134960
Phase 1Taking people
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
Where
Guangzhou, Hangzhou, Shanghai, Wuhan, Zhengzhou
Age
18 years and over
People
398 worldwide
Run by
Astellas Pharma Global Development, Inc.
See details and how to joinNCT05365581 · EU 2023-504514-29-00
Phase 2Not yet taking people in China
Retlirafusp Alfa Combined With Famitinib, Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Unresectable Pancreatic Cancer
Where
Zhengzhou
Age
18 years to 80 years
People
88
Run by
The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT07814859
Phase 3Not yet taking people in China
A Study to Compare the Efficacy and Safety of YL201 With Standard Chemotherapy in Patients With Metastatic Pancreatic Cancer After Failure of Gemcitabine-Based Systemic Chemotherapy
Where
Shanghai
Age
18 years to 75 years
People
320
Run by
MediLink Therapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT07803783
No phaseTaking people
IRE After Chemotherapy for Locally Advanced Pancreatic Cancer
Where
Tianjin
Age
18 years to 75 years
People
60
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07799935